ONLINE DATABASE SEARCH - HIV-LS-320-MEMO
1. 45161 HIV-LS-320; PUBMED-HIV-4/19/2005
Differential Inhibition of HIV-1 and SIV Envelope-Mediated Cell Fusion by C34 Peptides Derived from the C-Terminal Heptad Repeat of gp41 from Diverse Strains of HIV-1, HIV-2, and SIV
Gustchina, E, Hummer, G, Bewley, CA, and Clore, GM
J Med Chem 2005. 48(8): 3036-3044
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15828842&dopt=abstract
2. 45162 HIV-LS-320; EMBASE-HIV-4/19/2005
Suppression of Multidrug-resistant HIV-1 Reverse Transcriptase Primer Unblocking Activity by [alpha]-Phosphate-modified Thymidine Analogues
Matamoros, Tania, Deval, Jerome, Guerreiro, Catherine, Mulard, Laurence, Canard, Bruno, and Menendez-Arias, Luis
Journal of Molecular Biology 2005. In Press, Uncorrected Proof
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WK7-4G05H5S-4/2/68f2ac6a8fdd4d91ef6e41010529f28f
3. 45163 HIV-LS-320; PUBMED-HIV-4/19/2005
Inhibition of lysosome and proteasome function enhances human immunodeficiency virus type 1 infection
Wei, BL, Denton, PW, O'neill, E, Luo, T, Foster, JL, and Garcia, JV
J Virol 2005. 79(9): 5705-12
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15827185&dopt=abstract
4. 45164 HIV-LS-320; EMBASE-HIV-4/19/2005
Targeting HIV-1 integrase with aptamers selected against the purified RNase H domain of HIV-1 RT
Metifiot, Mathieu, Leon, Oscar, Tarrago-Litvak, Laura, Litvak, Simon, and Andreola, Marie-Line
Biochimie 2005. In Press, Uncorrected Proof
HYPERLINK:
http://www.sciencedirect.com/science/article/B6VRJ-4FXWT6S-3/2/951bbc8a0f3db8d2fd07b0af0df23741
5. 45165 HIV-LS-320; PUBMED-HIV-4/19/2005
Isolation and characterisation of novel cyclotides from viola hederaceae: Solution structure and anti-HIV activity of VHL-1, A leaf-specific-expressed cyclotide
Chen, B, Colgrave, ML, Daly, NL, Rosengren, KJ, Gustafson, KR, and Craik, DJ
J Biol Chem 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15824119&dopt=abstract
6. 45166 HIV-LS-320; PUBMED-HIV-4/19/2005
Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41
Liu, S, Lu, H, Zhao, Q, He, Y, Niu, J, Debnath, AK, Wu, S, and Jiang, S
Biochim Biophys Acta 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15823507&dopt=abstract
7. 45167 HIV-LS-320; PUBMED-HIV-4/19/2005
Concise synthesis and antiviral activity of novel unsaturated acyclic pyrimidine nucleosides
Oh, CH, Baek, TR, and Hong, JH
Nucleosides Nucleotides Nucleic Acids 2005. 24(2): 153-60
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15822621&dopt=abstract
8. 45168 HIV-LS-320; PUBMED-HIV-4/19/2005
Synthesis of (+/-)-4'-ethynyl and 4'-cyano carbocyclic analogues of stavudine (d4T)
Kumamoto, H, Haraguchi, K, Tanaka, H, Nitanda, T, Baba, M, Dutschman, GE, Cheng, YC, and Kato, K
Nucleosides Nucleotides Nucleic Acids 2005. 24(2): 73-83
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15822615&dopt=abstract
9. 45169 HIV-LS-320; PUBMED-HIV-4/19/2005
HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector
Anderson, J and Akkina, R
AIDS Res Ther 2005. 2(1): 1
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15813990&dopt=abstract
10. 45170 HIV-LS-320; PUBMED-HIV-4/19/2005
Deoxythreosyl Phosphonate Nucleosides as Selective Anti-HIV Agents
Wu, T, Froeyen, M, Kempeneers, V, Pannecouque, C, Wang, J, Busson, R, De, Clercq E, and Herdewijn, P
J Am Chem Soc 2005. 127(14): 5056-65
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15810840&dopt=abstract
11. 45171 HIV-LS-320; PUBMED-HIV-4/19/2005
Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic properties
Kim, D, Wang, L, Hale, JJ, Lynch, CL, Budhu, RJ, Maccoss, M, Mills, SG, Malkowitz, L, Gould, SL, Demartino, JA, Springer, MS, Hazuda, D, Miller, M, Kessler, J, Hrin, RC, Carver, G, Carella, A, Henry, K, Lineberger, J, Schleif, WA, and Emini, EA
Bioorg Med Chem Lett 2005. 15(8): 2129-34
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15808483&dopt=abstract
12. 45172 HIV-LS-320; PUBMED-HIV-4/19/2005
Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors
Harrigan, PR, Mo, T, Wynhoven, B, Hirsch, J, Brumme, Z, McKenna, P, Pattery, T, Vingerhoets, J, and Bacheler, LT
AIDS 2005. 19 (6): 549-54
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15802972&dopt=abstract
13. 45173 HIV-LS-320; PUBMED-HIV-4/19/2005
Enfuvirtide resistance mutations: impact on human immunodeficiency virus envelope function, entry inhibitor sensitivity, and virus neutralization
Reeves, JD, Lee, FH, Miamidian, JL, Jabara, CB, Juntilla, MM, and Doms, RW
J Virol 2005. 79(8): 4991-9
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15795284&dopt=abstract
14. 45174 HIV-LS-320; PUBMED-HIV-4/19/2005
Evaluation of an oligonucleotide ligation assay for detection of mutations in HIV-1 subtype C individuals who have high level resistance to nucleoside reverse transcriptase inhibitors and non-nucleoside reverse transcriptase inhibitors
Wallis, CL, Mahomed, I, Morris, L, Chidarikire, T, Stevens, G, Rekhviashvili, N, and Stevens, W
J Virol Methods 2005. 125(2): 99-109
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15794978&dopt=abstract
15. 45175 HIV-LS-320; PUBMED-HIV-4/19/2005
Lancifodilactone F: a novel nortriterpenoid possessing a unique skeleton from Schisandra lancifolia and its anti-HIV activity
Xiao, WL, Li, RT, Li, SH, Li, XL, Sun, HD, Zheng, YT, Wang, RR, Lu, Y, Wang, C, and Zheng, QT
Org Lett 2005. 7(7): 1263-6
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15787482&dopt=abstract
16. 45176 HIV-LS-320; EMBASE-HIV-4/19/2005
Antiviral activity in vitro of Urtica dioica L., Parietaria diffusa M. et K. and Sambucus nigra L.
Uncini Manganelli, RE, Zaccaro, L, and Tomei, PE
Journal of Ethnopharmacology 2005. 98(3): 323-327
HYPERLINK:
http://www.sciencedirect.com/science/article/B6T8D-4FK42K8-3/2/ba778eb59f0783537cf156ea902ee51c
17. 45177 HIV-LS-320; EMBASE-HIV-4/19/2005
Spectrum of antiviral activity of o-(acetoxyphenyl)hept-2-ynyl sulphide (APHS)
Pereira, Candida F, Rutten, Karla, Stranska, Ruzena, Huigen, Marleen CDG, Aerts, Piet C, de Groot, Raoul J, Egberink, Herman F, Schuurman, Rob, and Nottet, Hans SLM
International Journal of Antimicrobial Agents 2005. In Press, Corrected Proof
HYPERLINK:
http://www.sciencedirect.com/science/article/B6T7H-4FX23FV-1/2/28b9812c3725d3ddc542f22baedd31d1
18. 45178 HIV-LS-320; WOS-HIV-4/10/2005
The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor
Watson, C, Jenkinson, S, Kazmierski, W, and Kenakin, T
MOLECULAR PHARMACOLOGY 2005. 67(4): 1268-1282, 15
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000227805800033
19. 45179 HIV-LS-320; WOS-HIV-4/10/2005
The conserved glycine-rich segment linking the N-terminal fusion peptide to the coiled coil of human T-cell leukemia virus type 1 transmembrane glycoprotein gp21 is a determinant of membrane fusion function
Wilson, KA, Bar, S, Maerz, AL, Alizon, M, and Poumbourios, P
JOURNAL OF VIROLOGY 2005. 79(7): 4533-4539, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000227743700064
20. 45180 HIV-LS-320; WOS-HIV-4/10/2005
Aspartic proteases of Plasmodium falciparum as the target of HIV-1 protease inhibitors
Savarino, A, Cauda, R, and Cassone, A
JOURNAL OF INFECTIOUS DISEASES 2005. 191(8): 1381-1382, 2
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000227804500028
21. 45181 HIV-LS-320; WOS-HIV-4/10/2005
Synthesis and biological evaluation of branched and conformationally restricted analogs of the anticancer compounds 3'-C-ethynyluridine (EUrd) and 3'-C-ethynylcytidine (ECyd)
Hrdlicka, PJ, Andersen, NK, Jepsen, JS, Hansen, FG, Haselmann, KF, Nielsen, C, and Wengel, J
BIOORGANIC & MEDICINAL CHEMISTRY 2005. 13(7): 2597-2621, 25
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000227891000025
22. 45182 HIV-LS-320; WOS-HIV-4/17/2005
In silico studies toward the discovery of new anti-HIV nucleoside compounds through the use of TOPS-MODE and 2D/3D connectivity indices. 2. Purine derivatives
Vilar, S, Estrada, E, Uriarte, E, Santana, L, and Gutierrez, Y
JOURNAL OF CHEMICAL INFORMATION AND MODELING 2005. 45(2): 502-514, 13
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000228018000036
23. 45183 HIV-LS-320; WOS-HIV-4/17/2005
Marked structural and functional heterogeneity in CXCR4: Separation of HIV-1 and SDF-I alpha responses
Sloane, AJ, Raso, V, Dimitrov, DS, Xiao, XD, Deo, S, Muljadi, N, Restuccia, D, Turville, S, Kearney, C, Broder, CC, Zoellner, H, Cunningham, AL, Bendall, L, and Lynch, GW
IMMUNOLOGY AND CELL BIOLOGY 2005. 83(2): 129-143, 15
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000227953300004
24. 45184 HIV-LS-320; WOS-HIV-4/17/2005
Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression
Pinjon, E, Jackson, CJ, Kelly, SL, Sanglard, D, Moran, G, Coleman, DC, and Sullivan, DJ
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2005. 49(4): 1312-1318, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000228082500007